Skip to content

Epidemiology

What the Latest Research Reveals

Data last updated: 31 studies cited

How this page is produced

Generated by the ModernDoc Research Monitor from peer-reviewed literature. Every statistic is automatically checked against its cited source and screened for retractions before it is published. This page is AI-generated and has not yet been reviewed by a clinician β€” it is not medical advice. Read how we build and check these pages.

6.2%
of symptomatic individuals develop Long COVID symptom clusters
(95% UI: 2.4-13.3%)
Source: Global Burden of Disease Collaborators. JAMA (2022). 10.1001/jama.2022.18931 | n=1200000

KEY FINDINGS

This statistic is under review due to a verification issue.

Verification status: Pending
Brain Volume Loss
0.2-2%
95% CI: Additional grey matter loss vs controls (equivalent to ~1-7 years aging)
Source [13]
Reinfection Risk
2.17x
95% CI: HR 2.17 (95% CI: 1.93-2.45)
Source [8]

This statistic is under review due to a verification issue.

Vaccine protection against severe COVID-19 in solid organ transplant recipients during JN.1 wave
HR 0.88
95% CI: 95% CI 0.60-1.30
Source [31]
Vaccine protection against severe COVID-19 in bone marrow compromise patients during JN.1 wave
HR 0.64
95% CI: 95% CI 0.53-0.77
Source [31]
Vaccine protection against severe COVID-19 in active radio- or chemo-therapy patients during JN.1 wave
HR 0.68
95% CI: 95% CI 0.44-1.03
Source [31]
Vaccine protection against severe COVID-19 in active immunosuppressive medication patients during JN.1 wave
HR 0.68
95% CI: 95% CI 0.52-0.88
Source [31]
Vaccine protection against severe COVID-19 in primary or acquired immunodeficiency patients during JN.1 wave
HR 0.68
95% CI: 95% CI 0.55-0.82
Source [31]

THE TIMELINE

Acute Phase

0-4 weeks

Days 1-5 of symptoms; critical period days 7-10

Key Event
Peak viral shedding

Chronic Fatigue Development (>6 months)

Source: Multi-study comparison: Post-viral syndrome rates

Cumulative Risk with Each Reinfection

1 infection+Baseline
2 infections++110%
3+ infections+Further increase

β€œEach infection contributes additive risk, not replacement risk”

THE HOPEFUL HORIZON

  • Vaccination reduces Long COVID risk by 40-60%[3]
  • Paxlovid treatment shows 26% reduction in Long COVID symptoms[20]
  • 50-70% of Long COVID patients report improvement over time[11]
  • Active RECOVER initiative researching targeted treatments[0]

SOURCES

  1. [1]Lopez-Leon S, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Scientific Reports. 2021;11:16144. DOI (opens in new tab)
  2. [2]Chen C, et al. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. Journal of Infectious Diseases. 2022;226(9):1593-1607. DOI (opens in new tab)
  3. [3]Notarte KI, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022;53:101624. DOI (opens in new tab)
  4. [4]Global Burden of Disease Long COVID Collaborators. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604-1615. DOI (opens in new tab)
  5. [5]Ceban F, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain, Behavior, and Immunity. 2022;101:93-135. DOI (opens in new tab)

See a problem with the Epidemiology research summary?

Send a source correction or freshness concern. We cannot provide personal medical advice through this site.

Report a correction

SHARE THIS INFORMATION

Share with someone who needs to know

Data last updated:

Medical review: AI-generated β€” pending clinician review

Sources cited: 31 peer-reviewed sources

Claim verification: 2/6 verified (33%)

About DOIs

This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for medical decisions. Data is sourced from peer-reviewed publications and may be updated as new research emerges.